This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Jiangsu Hansoh Pharmaceutical Group Co., Ltd., Shanghai Hansoh Biomedical Co., Ltd.. Active years: 2026.
Company Filing History:
1 out of 9 
1 out of 9 Years Active: 2026
Title: Kailong Li: Innovator in Pharmaceutical Modulation
Introduction
Kailong Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate G protein-coupled receptors. His work is crucial for advancing treatments for central nervous system diseases and mental disorders.
Latest Patents
Kailong Li holds a patent for a "Modifier of four-membered ring derivative, preparation method and application thereof." This patent describes a compound represented by the general formula (IX-A), along with its preparation method and pharmaceutical applications. The compound is designed to act as a modulator for G protein-coupled receptors, which are vital in the treatment and prevention of various central nervous system and mental diseases.
Career Highlights
Throughout his career, Kailong Li has worked with notable companies in the pharmaceutical industry, including Shanghai Hansoh Biomedical Co., Ltd. and Jiangsu Hansoh Pharmaceutical Group Co., Ltd. His experience in these organizations has allowed him to contribute to innovative research and development in drug formulation and therapeutic applications.
Collaborations
Kailong Li has collaborated with esteemed colleagues such as Yidong Su and Xiaofeng Mao. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical sector.
Conclusion
Kailong Li's innovative work in pharmaceutical modulation exemplifies the impact of dedicated inventors in advancing medical science. His contributions are paving the way for new treatments that can significantly improve patient outcomes.